Safety and Outcomes of Test Doses for the Evaluation of Adverse Drug Reactions: A 5-Year Retrospective Review

Melissa Iammatteo, Kimberly G. Blumenthal, Rebecca Saff, Aidan A. Long, Aleena Banerji

Research output: Contribution to journalArticle

33 Scopus citations


Background: Graded challenges are the criterion standard for evaluating adverse drug reactions (ADR). Evidence-based guidelines regarding the optimal number of steps for challenges are lacking. Objective: To determine the safety and outcomes of 1- or 2-step test doses among patients with ADRs seen by the allergy/immunology consult service and to compare the outcomes of 1- or 2-step test doses with multistep challenges performed during the same time period. Methods: We conducted a retrospective chart review of all 1- or 2-step test doses and multistep challenges at a single academic center between 2008 and 2013. Patient demographics, symptoms of initial ADRs, and outcomes of test doses and multistep challenges were reviewed. ADRs were classified by type and were graded by severity. Outcomes of 1- or 2-step test doses were compared with multistep challenges. Results: We identified 456 patients who underwent 497 one- or 2-step test doses (mean age, 51 years; 67.5% female patients). The most common drugs that prompted test doses were β-lactams (62%). The majority of patients (n= 444 [89%]) did not experience any ADRs during test doses. ADRs that occurred during test doses (n= 53 [11%]) were most commonly non-immune-mediated (45%) or IgE-mediated (32%), with grade 1 or 2 severity (100%). Forty-nine percent of ADRs during test doses did not receive any treatment. The ADR rate during multistep challenges (10/82 [12%]) was similar to test doses. Conclusion: One- or 2-step test doses were safe for evaluation of ADRs. Multistep challenges did not confer added safety. Furthermore, 1- or 2-step test doses did not raise concern for induction of tolerance.

Original languageEnglish (US)
Pages (from-to)768-774
Number of pages7
JournalJournal of Allergy and Clinical Immunology: In Practice
Issue number6
StatePublished - Jan 1 2014



  • Adverse drug reaction
  • Drug allergy
  • Drug provocation test
  • Graded challenge
  • Hypersensitivity reaction
  • Test dose

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this